StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research note on Thursday, […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research note […]
HC Wainwright restated their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $28.00 target price on the biopharmaceutical company’s stock. Separately, StockNews.com began coverage on shares of Aeterna Zentaris in a report on Thursday. They set a […]
Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aeterna Zentaris in a […]
Research analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a report released on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of Aeterna Zentaris in a report […]